Summit Therapeutics Inc vs Teladoc Health Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Teladoc Health Inc trades at $9.7 (market cap $1.74B). The key difference: Summit Therapeutics Inc is far larger — about 6× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | TDOC | |
|---|---|---|
Market Cap | $10.48B | $1.74B |
Sector | Health | Health |
52-Week High | $29.32 | $9.72 |
52-Week Low | $13.05 | $4.47 |
Enterprise Value | $9.90B | $2.03B |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →